MedTrace Logo

The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury

NCT05977270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-03-10

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effects of Lifebloom One in people who have suffered a stroke or a traumatic brain injury.

The main questions to be answered are:

* Does Lifebloom One allow users to spend more time standing each day?
* Does Lifebloom One allow users to improve their balance and gait?

Participants will use Lifebloom One during 8 weeks.

For each participant, gait and balance are compared either with and without Oxilio or before and after Lifebloom One intervention.

Conditions

  • Stroke
  • Brain Injuries, Traumatic

Interventions

DEVICE

Lifebloom One

LBO is made of Oxilio, an alternative to wheelchair placement for everyday use.

Sponsors & Collaborators

  • Pitié-Salpêtrière Hospital

    collaborator OTHER

  • Lifebloom

    lead INDUSTRY

Principal Investigators

  • Eleonore Bayen, PUPH · Pitié-Salpêtrière Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2024-08-29
Completion
2024-08-29

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05977270 on ClinicalTrials.gov